Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Sorafenib in Treating Patients With Malignant Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | October 1, 2004 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00107432 |
| Study Type: | Interventional |
| Intervention: | Drug: sorafenib tosylate |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Cancer and Leukemia Group B|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | April 5, 2005 |
| End Date: | |
| Last Updated: | July 31, 2010 |
| Last Verified: | August 1, 2005 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
